Hemovigilance survey of pathogen-reduced blood components in the Warsaw Region in the 2009 to 2013 period

Transfusion

Volumn 56, Issue , 2016, Pages S39-S44

  Łętowska, Magdalena ^a   Przybylska, Zofia ^b   Piotrowski, Dariusz ^b   Lachert, Elzbieta ^a   Rosiek, Aleksandra ^a   Rzymkiewicz, Lech ^a   Cardoso, Marcia ^c  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^b Regional Centre of Blood Transfusion   (Poland)

^c Terumo BCT Europe NV   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA;

ACUTE LEUKEMIA; ADVERSE DRUG REACTION; ARTICLE; BLOOD COMPONENT; BLOOD DONOR; BLOOD SAFETY; BLOOD TRANSFUSION; COMPARATIVE STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; HEALTH SURVEY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; LIVER FAILURE; LYMPHOMA; MEDICAL RECORD; PATHOGEN REDUCTION SYSTEM; PRACTICE GUIDELINE; QUALITY CONTROL; SHOCK; STANDARD; THROMBOTIC THROMBOCYTOPENIC PURPURA; ADVERSE EFFECTS; FEMALE; MALE; PLASMA; POLAND; PROCEDURES; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RETROSPECTIVE STUDY; THROMBOCYTE; THROMBOCYTE TRANSFUSION;

BLOOD PLATELETS; BLOOD SAFETY; FEMALE; HUMANS; MALE; PLASMA; PLATELET TRANSFUSION; POLAND; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RETROSPECTIVE STUDIES;

EID: 84961792862     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13330     Document Type: Article

References (11)

1. Rosiek A, Tomaszewska A, Lachert E, et al., Blood transfusion service in Poland in 2012. J Transfus Med 2013; 6: 119-32.
2. Łętowska M, editor. Medyczne zasady pobierania krwi, oddzielania jej składników i wydawania obowiązujące w jednostkach organizacyjnych publicznej służby krwi [Medical standards for collection, preparation and distribution of blood and blood components]. 3rd ed. Warszawa: Instytut Hematologii i Transfuzjologii; 2014.
3. Guide to preparation, use and quality assurance of blood components. 17th ed. Strasbourg: EDQM Council of Europe; 2013.
4. Setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC [Internet]. Directive 2002/98/EC of the European Parliament and of the Council. Luxembourg: European Union Publications Office; 2003 Jan 27 [cited 2015 Feb 17]. Available from: http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2003:033:0030:0040:EN:PDF.
5. Łętowska M, Rosiek A., Podstawowe zasady leczenia krwią, jej składnikami i produktami krwiopochodnymi (essentials of clinical use of blood, blood components and plasma derivatives). VM Media, Gdańsk 2011; 6-10. 5
6. Implementing Directive 2002/98/EC of the European Parliament and of the Council as regards traceability requirements and notification of serious adverse reactions and events [Internet]. Commission Directive 2005/61/EC. Luxembourg: European Union Publications Office; 2005 Sep 30 [cited 2015 Feb 18]. Available from: http://ihn.withtoast.co.uk/wp-content/uploads/2011/02/directive-2005-61-ec.pdf
7. Cohn CS, Stubbs J, Schwartz J, et al., A comparison of adverse reaction rates for PAS C versus plasma platelet units. Transfusion 2014; 55: 1927-34.
8. Picker SM, Steisel A, Gathof BS., Evaluation of white blood cell- and platelet-derived cytokine accumulation in MIRASOL-PRT-treated platelets. Transfus Med Hemother 2009; 36: 114-20.
9. Marschner S, Fast LD, Baldwin WM, et al., White blood cell inactivation after treatment with riboflavin and ultraviolet light. Transfusion 2010; 50: 2489-249 8.
10. Asano H, Lee CY, Fox-Talbot K, et al., Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants. Transplantation 2007; 84: 1174-82.
11. Rizzo C, Rizzo S, Scirè E, et al., Thrombotic thrombocytopenic purpura: a review of the literature in the light of our experience with plasma exchange. Blood Transfus 2012; 10: 521-532.